跳至主要内容
临床试验/JPRN-UMIN000012210
JPRN-UMIN000012210已完成未知

Observational study for treatment outcome in patients with HER2-positive metastatic breast cancer who received pertuzumab combination chemotherapy. - Observational study for treatment outcome in patients with HER2-positive metastatic breast cancer who received pertuzumab combination chemotherapy.

Kurume University Hospital0 个研究点目标入组 10 人开始时间: 2013年11月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
10